Showing results (21-30 of 73) with videos related to
Sort By:
Pageof 8
Zhonghua Yi Xue Za Zhi|April 17, 2015
[Methodology comparison and influence factors analysis of epidermal growth factor receptor mutation detection]Xiaoyan Qian, Shuai Wang, Yinchen Shen, et al.BMC Cancer|December 23, 2025
Real-world analysis of subsequent-line strategies for EGFR C797S mutant non-small cell lung cancer patients acquired resistance to third-generation EGFR tyrosine kinase inhibitorsJianlin Xu, Anshun Zhu, Yingqi Xu, et al.Frontiers in Immunology|November 6, 2024
Prognostic role of serum cytokines level in non-small cell lung cancer patients with anti-PD-1 and chemotherapy combined treatmentHongyu Liu, Chao Zhou, Haohua Jiang, et al.Cancer Biomarkers : Section a of Disease Markers|July 11, 2013
Direct sequencing is a reliable assay with good clinical applicability for KRAS mutation testing in colorectal cancerJianfei Wang, Hongying Yang, Yinchen Shen, et al.Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 27, 2023
TRIM25 inhibition attenuates inflammation, senescence, and oxidative stress in microvascular endothelial cells induced by hyperglycemiaDandan Sun, Shenping Li, Shimei Chen, et al.Frontiers in Oncology|December 18, 2020
Clinical Features and Outcomes Analysis of Surgical Resected Pulmonary Large-Cell Neuroendocrine Carcinoma With Adjuvant ChemotherapyYinchen Shen, Fang Hu, Changhui Li, et al.Journal of Diabetes Investigation|February 11, 2018
Pro-apoptotic effects of micro-ribonucleic acid-365 on retinal neurons by targeting insulin-like growth factor-1 in diabetic rats: An in vivo and in vitro studyKairong Zheng, Ning Wang, Yinchen Shen, et al.Journal of Thoracic Disease|December 16, 2024
Neoadjuvant immunology therapy in patients with non-small cell lung cancer and chronic obstructive pulmonary diseaseQing Chang, Jiaqi Li, Yan Zhu, et al.Oncology Reports|January 3, 2020
Lung adenocarcinoma resistance to therapy with EGFR‑tyrosine kinase inhibitors is related to increased expression of cancer stem cell markers SOX2, OCT4 and NANOGFang Hu, Changhui Li, Xiaoxuan Zheng, et al.Frontiers in Pharmacology|October 6, 2022
Metabolomics study of treatment response to conbercept of patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathyYinchen Shen, Hanying Wang, Xiaoyin Xu, et al.Pageof 8